Tarceva® | |
Brand Name: | Tarceva® |
Active Ingredient: | erlotinib |
Strength(s): | 25 mg, 100 mg, 150 mg |
Dosage Form(s): | Tablet |
Company Name: | OSI Pharmaceuticals |
Availability: | Prescription only |
*Dated Approved by FDA: | November 19, 2004 |
*Approval by FDA does not mean that the drug is available for consumers at this time. |
What is Tarceva
used for? Tarceva is used to treat patients with advanced non-small cell lung cancer (NSCLC): ·
that
is only in the lung (local), or spread through the body (metastatic), and · who have failed at least one other chemotherapy treatment (medicine used to kill cancer cells) . Special
Warning(s) with Tarceva:
General
Precautions with Tarceva: Patients on Tarceva therapy and taking warfarin (Coumadin®)
or other medicines called "anti-coagulants" should have regular
blood tests and watch for bleeding problems. What should I
tell my health care provider? Tell your health care provider if you:
Know
the medicines you take. Keep a list and show it to your doctor and
pharmacist each time you get a new medicine.
Do not take any new medicines without talking to your doctor. What are some
possible side effects of Tarceva? (This list is
NOT a complete list of side effects reported with Tarceva.
Your health care provider can discuss with you a more complete list
of side effects.) Call your doctor right away if you have:
Some common side effects with Tarceva include:
For more
detailed information about Tarceva, ask your health care provider or
pharmacist. HTML by ghc |